Stockreport

Amylyx Refocuses On Avexatide As LUCIDITY Milestone Raises Stakes [Yahoo! Finance]

Amylyx Pharmaceuticals, Inc.  (AMLX) 
PDF Amylyx Pharmaceuticals has completed recruitment for its pivotal Phase 3 LUCIDITY trial of Avexatide for post bariatric hypoglycemia. The company is shifting its core [Read more]